A clinical-stage nonprofit biotechnology company, Cure Rare Disease, has acquired its first laboratory space in Woodbridge.
The organization will relocate its Boston headquarters to the 30,000-square-foot facility at 4 Research Drive and expand its research and development operations. The company plans to lease 15,000 square feet to other life science and healthcare firms.